BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 29619963)

  • 1. National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury.
    Haas-Kogan D; Indelicato D; Paganetti H; Esiashvili N; Mahajan A; Yock T; Flampouri S; MacDonald S; Fouladi M; Stephen K; Kalapurakal J; Terezakis S; Kooy H; Grosshans D; Makrigiorgos M; Mishra K; Poussaint TY; Cohen K; Fitzgerald T; Gondi V; Liu A; Michalski J; Mirkovic D; Mohan R; Perkins S; Wong K; Vikram B; Buchsbaum J; Kun L
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):152-168. PubMed ID: 29619963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors.
    Gentile MS; Yeap BY; Paganetti H; Goebel CP; Gaudet DE; Gallotto SL; Weyman EA; Morgan ML; MacDonald SM; Giantsoudi D; Adams J; Tarbell NJ; Kooy H; Yock TI
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):719-729. PubMed ID: 29413284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
    Giantsoudi D; Adams J; MacDonald SM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brainstem Injury in Pediatric Patients Receiving Posterior Fossa Photon Radiation.
    Devine CA; Liu KX; Ioakeim-Ioannidou M; Susko M; Poussaint TY; Huisman TAGM; Aboian M; Brown D; Zaslowe-Dude C; Rao AD; Orlina LT; Rawal B; Mueller S; Marcus KJ; Terezakis SA; Braunstein SE; Haas-Kogan DA
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1034-1042. PubMed ID: 31472183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury.
    Giantsoudi D; Sethi RV; Yeap BY; Eaton BR; Ebb DH; Caruso PA; Rapalino O; Chen YE; Adams JA; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):287-296. PubMed ID: 26691786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of brainstem necrosis in pediatric patients with central nervous system malignancies after pencil beam scanning proton therapy.
    Vogel J; Grewal A; O'Reilly S; Lustig R; Kurtz G; Minturn JE; Shah AC; Waanders AJ; Belasco JB; Cole KA; Fisher MJ; Phillips PC; Balamuth NJ; Storm PB; Hill-Kayser CE
    Acta Oncol; 2019 Dec; 58(12):1752-1756. PubMed ID: 31512931
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation of Acute and Late Brainstem Toxicities With Dose-Volume Data for Pediatric Patients With Posterior Fossa Malignancies.
    Nanda RH; Ganju RG; Schreibmann E; Chen Z; Zhang C; Jegadeesh N; Cassidy R; Deng C; Eaton BR; Esiashvili N
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):360-366. PubMed ID: 28463155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy.
    Indelicato DJ; Flampouri S; Rotondo RL; Bradley JA; Morris CG; Aldana PR; Sandler E; Mendenhall NP
    Acta Oncol; 2014 Oct; 53(10):1298-304. PubMed ID: 25279957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors.
    Upadhyay R; Liao K; Grosshans DR; McGovern SL; Frances McAleer M; Zaky W; Chintagumpala MM; Mahajan A; Nana Yeboa D; Paulino AC
    Neuro Oncol; 2022 Sep; 24(9):1571-1581. PubMed ID: 35157767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-control study of linear energy transfer and relative biological effectiveness related to symptomatic brainstem toxicity following pediatric proton therapy.
    Fjæra LF; Indelicato DJ; Handeland AH; Ytre-Hauge KS; Lassen-Ramshad Y; Muren LP; Stokkevåg CH
    Radiother Oncol; 2022 Oct; 175():47-55. PubMed ID: 35917900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative biological effectiveness (RBE) values for proton beam therapy.
    Paganetti H; Niemierko A; Ancukiewicz M; Gerweck LE; Goitein M; Loeffler JS; Suit HD
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):407-21. PubMed ID: 12023146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
    An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
    Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postsurgical geometrical variations of tumor bed and brainstem during photon and proton therapy for pediatric tumors of the posterior fossa: dosimetric impact and predictive factors.
    Volpe S; Bondiau PY; Claude L; Claren A; Padovani L; AlGhamdi H; Duhil De Benaze G; Opitz L; Baudin G; Dejean C; Maneval D; Jereczek-Fossa BA; Doyen J
    Strahlenther Onkol; 2021 Dec; 197(12):1113-1123. PubMed ID: 34351450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research progress on mechanism and dosimetry of brainstem injury induced by intensity-modulated radiotherapy, proton therapy, and heavy ion radiotherapy.
    Wei J; Shen Z; Wang H; Zhao Q; Ji R; Wang B; Xin Y; Jiang X
    Eur Radiol; 2020 Sep; 30(9):5011-5020. PubMed ID: 32318844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses.
    Sethi RV; Giantsoudi D; Raiford M; Malhi I; Niemierko A; Rapalino O; Caruso P; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):655-63. PubMed ID: 24521681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disregarding RBE variation in treatment plan comparison may lead to bias in favor of proton plans.
    Wedenberg M; Toma-Dasu I
    Med Phys; 2014 Sep; 41(9):091706. PubMed ID: 25186381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Treatment Toxicity Issues in Particle Therapy a Clarion Call for Biologic Treatment Planning Overall?
    Buchsbaum JC
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1085-1086. PubMed ID: 28332993
    [No Abstract]   [Full Text] [Related]  

  • 19. Conformal proton radiation therapy of the posterior fossa: a study comparing protons with three-dimensional planned photons in limiting dose to auditory structures.
    Lin R; Hug EB; Schaefer RA; Miller DW; Slater JM; Slater JD
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1219-26. PubMed ID: 11072181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results From the Imaging and Radiation Oncology Core Houston's Anthropomorphic Phantoms Used for Proton Therapy Clinical Trial Credentialing.
    Taylor PA; Kry SF; Alvarez P; Keith T; Lujano C; Hernandez N; Followill DS
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):242-248. PubMed ID: 27084644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.